Clinical trial
Does Dehydroepiandrosterone (DHEA) Improve IVF Outcomes in Poor Responders? A Randomised, Double-blind, Placebo Controlled Trial
NCT04066478 is registered in ClinicalTrials.gov with Homerton University Hospital NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Dehydroepiandrosterone (DHEA) Improve IVF Outcomes in Poor Responders? A Randomised, Double-blind, Placebo Controlled Trial
- Lead sponsor
- Homerton University Hospital NHS Foundation Trust
- Phase
- Phase 2/3
- Overall status
- Suspended
- Start date
- October 8, 2017
- Completion date
- December 31, 2022
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
infertility, female, poor response to ovulation induction